1. Background {#sec1}
=============

Enterobacteria, or gut microbiota, in the human gastrointestinal (GI) tract play important roles in the body\'s functions. For example, they can regulate immune responses and metabolic functions of the host \[[@B1]--[@B4]\]. The gut microbiota is frequently used to study the association between human health and an individual\'s lifestyle. In 2011, three major kinds of enterotypes consisting of*Bacteroides*,*Prevotella*, and*Ruminococcus* \[[@B5]\] provided new perspectives to classify individuals.*Ruminococcus* was reported to be an ambiguous enterotype, and the*Bacteroides* and*Prevotella* enterotypes were associated with dietary habits \[[@B6]\]. Animal protein and saturated fats were highly correlated with the*Bacteroides* enterotype. Low meat intake and plant-based nutrition with high carbohydrates were correlated with the*Prevotella* enterotype.

The Human Microbiome Project (HMP) \[[@B7]\] was launched by the US National Institutes of Health in 2008, and understanding the relationship between human health and microbiota that live in or on the human body was recognized as an important concept. To decipher this relationship, high-throughput sequencing, also called next-generation sequencing (NGS), supporting a large number of sequences, can be used to sequence 16S ribosomal (r)RNA to construct complex microbial community profiles. 16S rRNA is considered the standard for studying microbial communities and assigning taxonomy to bacteria. Compared to conventional polymerase chain reaction- (PCR-) based or culture-based methods, 16S rRNA sequencing by NGS can detect hundreds to thousands of bacteria at one time and offer relative quantification of the bacteria. Interactions between different bacterial communities and their environments can be comprehensively analyzed by metagenomics research. Associations between diseases and specific bacteria have been described in previous studies, for example, type 2 diabetes \[[@B8]--[@B11]\], irritable bowel syndrome (IBS) \[[@B12]--[@B14]\], and colorectal cancer (CRC) \[[@B15]--[@B17]\]. Moreover, some bacteria which are significantly associated with specific diseases were thought to be biomarkers for construction of a disease risk prediction model \[[@B8], [@B18]\].

Obesity is a major public health problem worldwide, and its prevalence is rapidly increasing \[[@B19]\]. Obesity is related to several disorders, including type 2 diabetes \[[@B20]--[@B23]\], cardiovascular disease \[[@B24]--[@B26]\], and cancer \[[@B26]--[@B28]\]. Recently, obesity was shown to be associated with an alteration of the gut microbiota, both in human \[[@B29]--[@B32]\] and animal models \[[@B30], [@B33], [@B34]\]. It was observed that a reduced proportion of the Bacteroidetes and increased proportion of the Firmicutes were associated with human obesity \[[@B30], [@B35], [@B36]\]. Also, an increase of*Actinobacteria* in obese individuals was reported \[[@B35]\]. In another study, amounts of Archaea and Methanobacteriales were positively correlated with obesity \[[@B37]\], and their amounts in obesity samples decreased or disappeared after gastric bypass surgery. In addition, another study also mentioned that the amounts of*Bifidobacterium* and*Ruminococcus* decreased in obesity samples \[[@B38]\]. However, some studies indicated that the ratio of the proportions of Bacteroidetes and Firmicutesis contradictory \[[@B39]\] or not associated \[[@B5], [@B40]\] with obesity.

With different ethnicities and regions, dietary habits and environmental factors can widely vary, and there is a lack of studies focusing on Taiwanese samples. Therefore, herein we collected 81 stool samples from Taiwanese for analysis of the association between gut flora and obesity. According to a study by Pan et al. \[[@B41]\], Taiwan adopted body mass index (BMI) values of 24 and 27 as the cutoff points for being overweight and obese, respectively. In this study, the stools of 36 obese (BMI ≥ 27) and 45 normal persons (BMI ≤ 24) were collected, and 16S rRNA sequencing was used to assess the association between obesity and the taxonomic composition of the gut microbiota.

2. Results {#sec2}
==========

Participant metadata are summarized in [Table 1](#tab1){ref-type="table"}, and detailed sample profiles are given in Table S1 available online in Supplementary material at <http://dx.doi.org/10.1155/2014/906168>, including the number of reads, gender, age, height, weight, and BMI. In total, 4,152,740 sequence reads were obtained from the 81 samples, and a mean of 51,268 reads with a median read length of 125 bp was obtained per study participant. Sequence reads were processed through our taxonomic mapping process, and the distribution of genera in samples is depicted in [Figure 1](#fig1){ref-type="fig"}. The sequencing results showed that the most abundant genera in all samples were*Bacteroides* (28%),*Prevotella* (20%),*Escherichia* (9.7%),*Phascolarctobacterium* (3.9%),*Eubacterium* (3.2%),*Megamonas* (3%),*Faecalibacterium* (2.9%),*Gemmiger* (2.2%), and*Sutterella* (2%).

2.1. Unsupervised Clustering Analysis {#sec2.1}
-------------------------------------

Hierarchical clustering was performed using the UniFrac unweighted distance, and gut bacterial communities and clinical values of each sample are shown in [Figure 2](#fig2){ref-type="fig"}. The results demonstrate that the bacterial communities in the gut were clustered into two main groups: an N-like group (including the N1 and N2 subgroups) and an OB-like group (including the OB1, OB2, OB3, and OB4 subgroups). [Figure 3](#fig3){ref-type="fig"} shows that the most abundant genera in N-like samples were*Bacteroides* (27.8%),*Prevotella* (18.6%),*Escherichia* (12.7%),*Phascolarctobacterium* (4%), and*Eubacterium* (3.5%). The most abundant genera in OB-like samples were*Bacteroides* (28.8%),*Prevotella* (21.7%),*Escherichia* (7.1%),*Megamonas* (4.4%), and*Phascolarctobacterium* (3.7%). Remarkably, most normal samples (78%) were clustered in the N-like group, and most case samples (81%) were clustered in the OB-like group (Fisher\'s *P* value = 1.61*E* − 07). The results showed that gut bacterial community types were highly associated with obesity. The genera diversity analysis showed that the bacterial communities in the N-like group exhibited significantly higher alpha diversity and lower beta diversity than those in the OB-like group ([Figure 4](#fig4){ref-type="fig"}).

2.2. Supervised Clustering Analysis {#sec2.2}
-----------------------------------

To investigate the association between gut bacterial communities and obesity, 45 stool samples of participants with a BMI of ≤ 24 were defined as normal samples, and 36 samples of participants with a BMI ≥ 27 were used as case samples. [Figure 5](#fig5){ref-type="fig"} shows that the most abundant bacteria in normal samples were*Bacteroides* (27.7%),*Prevotella* (19.4%),*Escherichia* (12%),*Phascolarctobacterium* (3.9%), and*Eubacterium* (3.5%). The most abundant bacteria in case samples were*Bacteroides* (29%),*Prevotella* (21%),*Escherichia* (7.4%),*Megamonas* (5.1%), and*Phascolarctobacterium* (3.8%). Normal samples had a significantly higher proportion of*Escherichia*, while case samples had a higher proportion of*Megamonas*.

Genera with significantly different proportions between normal and case samples are listed in [Table 2](#tab2){ref-type="table"}. Additionally, genera with a significantly different presence between normal and case samples are listed in [Table 3](#tab3){ref-type="table"}, and significantly different species are also provided in Table S2. The genera of*Shewanella, Citrobacter, Cronobacter, Leclercia, Tatumella, and Acinetobacter* exhibited significant differences in both proportions and presence. Unweighted alpha and beta diversities of genera in the normal and case samples are shown in Figures [6(a)](#fig6){ref-type="fig"} and [6(b)](#fig6){ref-type="fig"}, respectively. The results showed that the bacterial communities in normal samples exhibited significantly higher alpha diversity and lower beta diversity than those in case samples.

A PCoA of gut bacterial communities is shown in [Figure 7](#fig7){ref-type="fig"}. The results showed that most normal samples (green nodes) were located in the bottom left area, and case samples (red nodes) were spread in other areas ([Figure 7(a)](#fig7){ref-type="fig"}). Samples in the N1, N2, OB1, OB2, OB3, and OB4 subgroups are depicted in [Figure 7(b)](#fig7){ref-type="fig"}. The results show that bacterial communities of N1 and N2 were highly associated with normal-weight individuals, and others were associated with obese individuals.

2.3. Potential Markers for Classification of Normal Weight and Obesity {#sec2.3}
----------------------------------------------------------------------

The identified bacteria with statistical significance were used for rule-based clustering. Threefold cross-validation was used to evaluate the performance of the classification model. Two out of the significant species in Table S2,*Parabacteroides distasonis* and*Serratia*sp.*DAP4*, were selected as discriminating factors in the J48 decision tree. As shown in [Figure 8](#fig8){ref-type="fig"}, the classification rules are described as follows. (1) a sample is classified as normal if*Parabacteroides distasonis* was absent. (2) A sample with the presence of*Parabacteroides distasonis* and absence of*Serratia* sp.*DAP4* was classified as a case; otherwise, it was classified as normal. As shown in Table S3, the classifier performed well, and the area under the receiver operating characteristic curve (AUC) was 0.813. The results showed that*Parabacteroides distasonis* and*Serratia* sp.*DAP4* might be potential markers for further clinical analysis and investigation of obesity.

3. Discussion {#sec3}
=============

Several relatively abundant genera were identified in samples ([Figure 5](#fig5){ref-type="fig"}), including*Bacteroides*,*Prevotella*,*Escherichia*,*Phascolarctobacterium*,*Eubacterium*,*Megamonas*,*Faecalibacterium*,*Gemmiger*,*Sutterella*,*Fusobacterium*,*Salmonella*,*Megasphaera*,*Dialister*,*Bifidobacterium*, and*Akkermansia*. In previous studies, the presence of*Bacteroides*,*Prevotella,* and*Sutterella* was negatively associated with obesity \[[@B36], [@B42], [@B43]\]. In other related gastrointestinal diseases,*Prevotella* was increased in children diagnosed with IBS \[[@B44]\].*Bacteroides*,*Eubacterium,* and*Prevotella* were increased, and*Faecalibacterium* was reduced in CRC patients \[[@B45], [@B46]\]. Increased*Bacteroides* and reduced*Eubacterium* and*Prevotella* were also found in a rat model of CRC \[[@B47]\].

At the genus level, the presence of*Acinetobacter*,*Aliivibrio*,*Marinomonas*,*Pseudoalteromonas*, and*Shewanella* had positive associations with obesity ([Table 3](#tab3){ref-type="table"}).*Acinetobacter* is a genus of Gram-negative bacteria, and the species*Acinetobacter baumannii* is a key pathogen of infections in hospitals \[[@B48]\].*Aliivibrio* is a reclassified genus from the "*Vibrio fischeri* species group" \[[@B49]\], and species of*Aliivibrio* are symbiotic with marine animals or are described as fish pathogens \[[@B50]--[@B52]\].*Shewanella* is a genus of marine bacteria, and some species can cause infections \[[@B53], [@B54]\].*Lachnospira* \[[@B37]\],*Citrobacter* \[[@B43]\], and*Shigella*\[[@B43]\] were reported to be positively associated with obesity.*Lachnobacterium* \[[@B18]\] showed a negative association with obesity.

At the species level, the presence of*Parabacteroides distasonis*,*Lactobacillus kunkeei*,*Pseudoalteromonas piscicida*,*Shewanella algae*,*Marinomonas posidonica*, and*Aliivibrio fischeri* was positively associated with obesity (Table S2). Species of*Bacteroides* and*Parabacteroides* represent opportunistic pathogens in infectious diseases, and they are able to develop antimicrobial drug resistance \[[@B55]\].*Parabacteroides distasonis*, previously known as*Bacteroides distasonis* \[[@B56]\], is prominently found in the gut of healthy individuals \[[@B57]\]. It is also related to improved human bowel health release \[[@B58]\] and negatively associated with celiac disease \[[@B59]\]. Our results revealed a positive association between*Parabacteroides distasonis* and obesity.*Blautia producta* \[[@B60]\] and*Enterobacter cloacae* \[[@B61]\] were suggested to be related to a high-fat diet causing obesity in a mouse model.*Serratia* is a genus of Gram-negative, facultatively anaerobic, rod-shaped bacteria. In hospitals,*Serratia* species tend to colonize the respiratory and urinary tracts causing nosocomial infections \[[@B62], [@B63]\]. In related studies of the GI tract,*Serratia* increased in formula-fed mice \[[@B64]\] and was positively correlated with infants with colic \[[@B65]\].

In the alpha diversity analysis ([Figure 6(a)](#fig6){ref-type="fig"}), the Chao richness index between normal and case groups exhibited a significant difference (*P* = 0.002). This shows that bacterial communities in normal samples had a greater genera richness than those in case samples. Results of the beta diversity analysis ([Figure 6(b)](#fig6){ref-type="fig"}) showed that bacterial communities in normal samples were more similar than those in case samples. The unweighted PCoA plot ([Figure 7](#fig7){ref-type="fig"}) showed that bacterial communities in the N-like group (including N1 and N2) were highly associated with normal individuals, and bacterial communities in the OB-like group (including OB1, OB2, OB3, and OB4) were more associated with obese individuals. The unsupervised clustering heatmap of all samples (Figure S1(A)) was generated using Spearman correlations, and the results showed that most normal samples and most case samples were, respectively, clustered together, when all genera were used for clustering. However, when only relatively abundant genera were used for clustering, normal, and case samples were interwoven with each other (Figure S1(B)). This indicates that some genera found in small proportions might be important for distinguishing obese from normal individuals.

4. Conclusions {#sec4}
==============

This is the first study in Taiwan to investigate the association between human gut microbiota and obesity using metagenomic sequencing. The results showed that bacterial communities in the gut were clustered into N-like and OB-like groups which were highly associated with normal and obese subjects, respectively. Several relatively abundant bacteria with significantly different distributions between normal and case samples were identified and used to establish a rule-based classification model. Although detailed functional roles or mechanisms of these bacteria are needed for further validation, the results provide new insights about bacterial communities in the gut with a rising trend of obesity.

5. Methods {#sec5}
==========

5.1. Sample Collection and DNA Extraction {#sec5.1}
-----------------------------------------

Eighty-one stool samples were collected by Sigma-transwab (Medical Wire) into a tube with Liquid Amies Transport Medium and stored at 4°C until being processed. Fresh faeces were obtained from participants, and DNA was directly extracted from stool samples using a QIAamp DNA Stool Mini Kit (Qiagen). A swab was vigorously vortexed and incubated at room temperature for 1 min. The sample was transferred to microcentrifuge tubes containing 560 *μ*L of Buffer ASL, then vortexed, and incubated at 37°C for 30 min. In addition, the suspension was incubated at 95°C for 15 min, vortexed, and centrifuged at 14,000 rpm for 1 min to obtain pelletized stool particles. Extraction was performed following the protocol of the QIAamp DNA Stool Mini Kit. DNA was eluted with 50 *μ*L Buffer AE, centrifuged at 14,000 rpm for 1 min, and then the DNA extract was stored at −20°C until being further analyzed.

5.2. Library Construction and Sequencing of the V4 Region of 16S rDNA {#sec5.2}
---------------------------------------------------------------------

The PCR primers, F515 (5′-GTGCCAGCMGCCGCGGTAA-3′) and R806 (5′-GGACTACHVGGGTWTCTAAT-3′), were designed to amplify the V4 region of bacterial 16S rDNA as described previously \[[@B66]\]. Polymerase chain reaction (PCR) amplification was performed in a 50 *μ*L reaction volume containing 25 *μ*L 2x Taq Master Mix (Thermo Scientific), 0.2 *μ*M of each forward and reverse primer, and 20 ng of a DNA template. The reaction conditions included an initial temperature of 95°C for 5 min, followed by 30 cycles of 95°C for 30 s, 54°C for 1 min, and 72°C for 1 min, with a final extension of 72°C for 5 min. Next, amplified products were checked by 2% agarose gel electrophoresis and ethidium bromide staining. Amplicons were purified using the AMPure XP PCR Purification Kit (Agencourt) and quantified using the Qubit dsDNA HS Assay Kit (Qubit) on a Qubit 2.0 Fluorometer (Qubit), all according to the respective manufacturer\'s instructions. For V4 library preparation, Illumina adapters were attached to the amplicons using the Illumina TruSeq DNA Sample Preparation v2 Kit. Purified libraries were processed for cluster generation and sequencing using the MiSeq system.

5.3. Filtering 16S rRNA (rDNA) Sequencing Data for Quality {#sec5.3}
----------------------------------------------------------

The FASTX-Toolkit (<http://hannonlab.cshl.edu/fastx_toolkit>) was used to process the raw fastq read data files from Illumina Miseq. The sequence quality criteria were as follows: (1) the minimum acceptable phred quality score of sequences was 30 with a score of \>70% of sequence bases of ≥20; (2) after quality trimming from the sequence tail, sequences of \>100 bp were retained, and they also had an acceptable phred quality score of 30; and (3) both forward and reverse sequencing reads which met the first and second requirements were retained for subsequent analysis. Sequencing reads from different samples were identified and separated according to specific barcodes in the 5′ end of the sequence (with two mismatches allowed).

5.4. Taxonomic Assignments of Bacterial 16S rRNA Sequences {#sec5.4}
----------------------------------------------------------

Paired-end sequences were obtained, and their qualities were assessed using the FASTX-Toolkit. To generate taxonomic assignments, Bowtie2 was used to align sequencing reads against the collection of a 16S rRNA sequences database. A standard of 97% similarity against the database was applied. 16S rRNA sequences of bacteria were retrieved from the SILVA ribosomal RNA sequence database \[[@B67]\]. Following sequence data collection, sequences were extracted using V4 forward and reverse primers. To prevent repetitive sequence assignments, V4 sequences from SILVA were then clustered into several clusters by 97% similarity using UCLUST \[[@B68]\]. Results of the taxonomic assignment were filtered to retain assignments with \>10 sequences.

5.5. Bacterial Community Analysis {#sec5.5}
---------------------------------

After taxonomic assignment, an operational taxonomic unit (OTU) table was generated. To normalize the sample size of all samples, a rarefaction process was performed on the OTU table. Alpha and beta diversities were calculated based on a rarified OTU table. The Kolmogorov-Smirnov test and an analysis of variance (ANOVA) test with the Bonferroni correction were used to investigate significant differences between different sample groups. To observe relationships between samples and explore taxonomic associations, weighted and unweighted UniFrac \[[@B69]\] distance metrics were also generated based on the rarified OTU table. A principal coordinate analysis (PCoA) and unsupervised clustering were performed based on the UniFac distance matrix. To explore relationships between clinical features and different sample groups, Spearman\'s correlation coefficient and regression analysis were performed. The statistical analytical process was done in R language. The J48 machine learning method in Weka 3.6.7 \[[@B70]\] was used to construct a classification rule for discriminating between obese and normal individuals.

Supplementary Material {#supplementary-material-sec}
======================
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Table S2: Species with a significantly different presence between normal and case samples

S3: Performance of classification of obesity and normal using Parabacteroides distasonis and Serratia sp. DAP4
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###### 

Study participant characteristics and demographics.

  ----------------------------------------------- ------------
  *Participant characteristic*                     
  Gender (number of samples)                       
   Male                                           30
   Female                                         51
  Age (years)                                      
   Range                                          20\~89
   Mean                                           41.2
  Height (cm)                                      
   Range                                          148.5\~181
   Mean                                           164
  Weight (kg)                                      
   Range                                          45\~110
   Mean                                           69.7
  Body mass index (kg/m^2^) (number of samples)    
   ≤24                                            45
   ≥27                                            36
  ----------------------------------------------- ------------

###### 

Genera with significantly different proportions between normal and case samples.

  -------------------------------------------------------------------------------------
  Genus             Fold change\     KS test\    ANOVA\      Case mean   Control mean
                    (case/control)   *P* value   *P* value               
  ----------------- ---------------- ----------- ----------- ----------- --------------
  *Collinsella*     0.56             0.01        0.37        0.001       0.002

  *Barnesiella*     0.61             0.01        0.26        0.002       0.003

  *Clostridium*     0.52             0.01        0.01        0.009       0.017

  *Coprococcus*     0.54             0.04        0.37        0.001       0.001

  *Lachnospira*     1.68             0.02        0.27        0.003       0.002

  *Oscillibacter*   0.55             0.01        0.02        0.001       0.001

  *Megamonas*       5.70             0.08        0.01        0.051       0.009

  *Veillonella*     0.47             0.01        0.27        0.002       0.004

  *Shewanella*      4.69             0.00        0.04        0.001       \<0.001

  *Citrobacter*     0.26             0.00        0.11        0.002       0.006

  *Cronobacter*     0.08             0.00        0.00        \<0.001     0.002

  *Enterobacter*    0.38             0.00        0.07        0.001       0.002

  *Erwinia*         0.18             0.00        0.00        \<0.001     0.002

  *Escherichia*     0.62             0.00        0.04        0.074       0.120

  *Leclercia*       0.09             0.00        0.06        0.001       0.005

  *Morganella*      0.05             0.01        0.07        \<0.001     0.001

  *Serratia*        0.02             0.00        0.00        \<0.001     0.018

  *Tatumella*       0.06             0.00        0.00        \<0.001     0.001

  *Halomonas*       3.51             0.00        0.08        0.005       0.002

  *Acinetobacter*   116.08           0.00        0.03        0.002       \<0.001
  -------------------------------------------------------------------------------------

KS: Kolmogorov-Smirnov; ANOVA: analysis of variance.

###### 

Genera with a significantly different presence between normal and case samples.

  ---------------------------------------------------------------------------------------------
  Genus                 Presence\     Absence\      Fisher\'s test\   Odds ratio\
                        Case/normal   Case/normal   *P* value         (95% CI)
  --------------------- ------------- ------------- ----------------- -------------------------
  *Butyricimonas*       28/44         8/1           0.009             0.082 (0.002\~0.664)

  *Butyrivibrio*        0/11          36/34         0.001             0.088 (0.002\~0.663)

  *Lachnobacterium*     0/16          36/29         \<0.001           0.052 (0.001\~0.371)

  *Lachnospira*         22/43         14/2          \<0.001           0.076 (0.008\~0.373)

  *Syntrophococcus*     0/10          36/35         0.002             0.099 (0.002\~0.764)

  *Pectinatus*          0/14          36/31         \<0.001           0.063 (0.001\~0.460)

  *Comamonas*           0/10          36/35         0.002             0.099 (0.002\~0.764)

  *Pseudoalteromonas*   12/1          24/44         \<0.001           21.261 (2.837\~956.295)

  *Shewanella*          15/3          21/42         \<0.001           9.703 (2.381\~58.040)

  *Citrobacter*         17/43         19/2          \<0.001           0.043 (0.004\~0.210)

  *Cronobacter*         6/34          30/11         \<0.001           0.068 (0.018\~0.218)

  *Leclercia*           8/36          28/9          \<0.001           0.075 (0.021\~0.233)

  *Rahnella*            0/13          36/32         \<0.001           0.070 (0.002\~0.516)

  *Shigella*            5/31          31/14         \<0.001           0.076 (0.019\~0.250)

  *Tatumella*           2/23          34/22         \<0.001           0.058 (0.006\~0.273)

  *Marinomonas*         12/1          24/44         \<0.001           21.261 (2.837\~956.295)

  *Acinetobacter*       12/2          24/43         0.001             10.443 (2.070\~103.809)

  *Aliivibrio*          8/1           28/44         0.009             12.231 (1.505\~568.466)
  ---------------------------------------------------------------------------------------------

CI: confidence interval.

[^1]: Academic Editor: Li-Ching Wu
